CTOs on the Move

Lumagenics

www.lumagenics.com

 
At Lumagenics, we’re developing innovative solutions to safely, swiftly, and precisely eradicate the threat of even the most resistant pathogens in our most vulnerable industries. We don’t believe in resting on past success, but continually seek out better solutions that ensure the safety of others while protecting business investments. Through decades of research and development, we have engineered our photonic system to generate an intense, precisely-controlled spectrum of UV light. We do this without generating excess heat – a technology we call “Cool UV”. Our technology can be applied to Air, Water, and Surface Disinfection. Lumagenics is currently ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Steve Grenon
Chief Operating Officer Profile

Similar Companies

Chicago Lake Shore Medical Associates

Chicago Lake Shore Medical Associates is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bryan Medical Group

Bryan Medical Group, Inc. is a Bryan, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Greater Hudson Valley Health System

A member of the Greater Hudson Valley Health System (GHVHS), Catskill Regional Medical Center (CRMC) is dedicated to providing the highest quality health care to residents of Sullivan County and neighboring communities at its main hospital campus in Harris and at Grover M. Hermann Hospital in Callicoon. The sole community provider of health care in Sullivan County, CRMC offers the most technologically up-to-date methods of diagnosis and treatment.

St. Mary's Hospital

St. Mary's Hospital is a Passaic, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Helius Medical

At Helius Medical Technologies, we`re using the power of our collective curiosity, talent, and experience to change the lives of those affected by neurologic diseases such as traumatic brain injury, multiple sclerosis, stroke, and cerebral palsy. We know how symptoms of these brain disorders can marginalize those affected and we`re committed to changing that dynamic through the development of new neurotech treatments that will reset both the standards and expectations of care. Our first innovation is the Portable Neuromodulation Stimulator, or PoNS®, an investigational, non-invasive therapy that combines stimulation of the trigeminal nerve through the tongue with focused rehabilitation to unlock the brain`s ability to restore lost function.